Rezolute (RZLT) Assets Average (2011 - 2026)
Rezolute (RZLT) reported Assets Average of $132.0 million for Q1 2026, up 27.74% on a YoY basis from $103.4 million in Q1 2025, and down 11.17% sequentially from $148.6 million in Q4 2025.
Rezolute (RZLT) Assets Average (2011 - 2026) Analysis & Trends
Rezolute (RZLT) has 16 years of Assets Average data on file, last reported at $132.0 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average rose 27.74% year-over-year to $132.0 million; the trailing twelve-month figure through Mar 2026 stood at $132.0 million (up 27.74% YoY), and the FY2025 full-year result was $154.1 million, up 20.19% from the prior year.
- Assets Average eased to $132.0 million in Q1 2026, from $148.6 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $167.1 million in Q3 2025 to a low of $76.5 million in Q1 2022.
- A 5-year average of $125.2 million and a median of $128.1 million in 2024 frame the typical range for Assets Average.
- Across the five-year window, Assets Average surged 279.02% in 2022 and tumbled 33.24% in 2024, its largest moves.
- Tracing RZLT's Assets Average over 5 years: stood at $153.1 million in 2022, then slipped by 29.73% to $107.6 million in 2023, then climbed by 9.42% to $117.7 million in 2024, then increased by 26.28% to $148.6 million in 2025, then dropped by 11.17% to $132.0 million in 2026.
- Business Quant data shows RZLT's Assets Average at $132.0 million in Q1 2026, $148.6 million in Q4 2025, and $167.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 65.01 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 40.89 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 8.37 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 2.30 Bn |
| 10 | Rezolute | 518.12 Mn | 518.12 Mn | - | 132.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 132.04 Mn |
| Dec 31, 2025 | 148.65 Mn |
| Sep 30, 2025 | 167.08 Mn |
| Jun 30, 2025 | 135.11 Mn |
| Mar 31, 2025 | 103.37 Mn |
| Dec 31, 2024 | 117.71 Mn |
| Sep 30, 2024 | 128.08 Mn |
| Jun 30, 2024 | 110.24 Mn |
| Mar 31, 2024 | 94.94 Mn |
| Dec 31, 2023 | 107.57 Mn |
| Sep 30, 2023 | 118.36 Mn |
| Jun 30, 2023 | 128.96 Mn |
| Mar 31, 2023 | 142.21 Mn |
| Dec 31, 2022 | 153.10 Mn |
| Sep 30, 2022 | 154.20 Mn |
| Jun 30, 2022 | 111.00 Mn |
| Mar 31, 2022 | 76.49 Mn |
| Dec 31, 2021 | 61.08 Mn |
| Sep 30, 2021 | 40.68 Mn |
| Jun 30, 2021 | 37.77 Mn |